Literature DB >> 28010152

Consider stopping dengvaxia administration without immunological screening.

Maíra Aguiar1, Scott B Halstead2, Nico Stollenwerk1.   

Abstract

Keywords:  Dengvaxia; immunological screening; modeling; prediction; vaccine disease-enhancement

Mesh：

Substances：

Year:  2016        PMID： 28010152     DOI： 10.1080/14760584.2017.1276831

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  9 in total

1.  Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain.

Authors:  Akhil Kumar Srivasrav; Nico Stollenwerk; Joseba Bidaurrazaga Van-Dierdonck; Javier Mar; Oliver Ibarrondo; Maíra Aguiar
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

2.  Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests.

Authors:  Aaron L Oom; Davey Smith; Kevan Akrami
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

3.  Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.

Authors:  Miao Wang; Fan Yang; Dana Huang; Yalan Huang; Xiaomin Zhang; Chao Wang; Shaohua Zhang; Renli Zhang
Journal:  Front Cell Infect Microbiol       Date:  2017-05-09       Impact factor: 5.293

4.  Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study.

Authors:  Hugo C Turner; Bridget A Wills; Motiur Rahman; Hoang Quoc Cuong; Guy E Thwaites; Maciej F Boni; Hannah E Clapham
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-08-01       Impact factor: 2.184

5.  Dengue-like illness surveillance: a two-year longitudinal survey in suburban and rural communities in the Lao People's Democratic Republic and in Thailand.

Authors:  Nanthasane Vannavong; Razak Seidu; Thor Axel Stenström; Nsa Dada; Hans Jørgen Overgaard
Journal:  Western Pac Surveill Response J       Date:  2019-02-19

6.  The effectiveness of inspections on reported mosquito larval habitats in households: A case-control study.

Authors:  Joel Aik; Zhi Wei Neo; Jayanthi Rajarethinam; Kaiyun Chio; Wing Mun Lam; Lee-Ching Ng
Journal:  PLoS Negl Trop Dis       Date:  2019-06-26

7.  Multivariate time-series analysis of biomarkers from a dengue cohort offers new approaches for diagnosis and prognosis.

Authors:  Baptiste Vasey; Anuraj H Shankar; Bobby Brooke Herrera; Aniuska Becerra; Kris Xhaja; Marion Echenagucia; Sara R Machado; Diana Caicedo; John Miller; Paolo Amedeo; Elena N Naumova; Irene Bosch
Journal:  PLoS Negl Trop Dis       Date:  2020-06-16

8.  Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.

Authors:  Stefan W Metz; Ashlie Thomas; Alex Brackbill; Yi Xianwen; Michele Stone; Katie Horvath; Michael J Miley; Chris Luft; Joseph M DeSimone; Shaomin Tian; Aravinda M de Silva
Journal:  PLoS Negl Trop Dis       Date:  2018-09-24

9.  Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection.

Authors:  Heidi Auerswald; Simone Kann; Leonard Klepsch; Janne Hülsemann; Ines Rudnik; Sebastian Schreiber; Philippe Buchy; Michael Schreiber
Journal:  Viruses       Date:  2021-09-29       Impact factor: 5.048
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.